Novartis is a leading global healthcare company headquartered in Basel, Switzerland, dedicated to reimagining medicine to improve and extend people's lives. Founded in 1996 through the merger of Ciba-Geigy and Sandoz, Novartis operates in over 150 countries and employs more than 100,000 people worldwide. The company focuses on innovative medicines, generics, and eye care products, with a strong emphasis on research and development to address unmet medical needs.
Novartis' mission is to discover new ways to improve health and well-being, leveraging cutting-edge science and technology. It maintains a robust pipeline across therapeutic areas such as oncology, cardiovascular, immunology, neuroscience, and ophthalmology. In recent years, Novartis has been recognized for breakthroughs in gene therapy, including treatments for rare diseases, and has advanced digital health initiatives to enhance patient outcomes. The company consistently ranks among the world's top pharmaceutical firms by revenue and reputation, underscoring its commitment to innovation and patient-centric care.